Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
British Biotech's Marimistat Fails In Promising Indication
Feb. 14, 2001
By
Nuala Moran
Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study
Feb. 14, 2001
By
Nuala Moran
Acambis Achieves Early Results That Validate Flavivirus Vaccine
Feb. 14, 2001
By
Nuala Moran
KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial
Feb. 14, 2001
By
Nuala Moran
Antisoma Planning Financing To Stay Ahead, Keep Flexibility
Feb. 14, 2001
By
Nuala Moran
British Biotech's Marimistat Fails In Promising Indication
Feb. 14, 2001
By
Nuala Moran
Protherics Gains U.S. Approval Of CroFab, Raises £3.1M Privately
Feb. 7, 2001
By
Nuala Moran
SR Pharma, YM Biosciences Combine Products For Trial
Feb. 7, 2001
By
Nuala Moran
SR Pharma, YM Biosciences Combine Products For Trial
Feb. 7, 2001
By
Nuala Moran
Protherics Gains U.S. Approval Of CroFab, Raises £3.1M Privately
Feb. 7, 2001
By
Nuala Moran
Previous
1
2
…
505
506
507
508
509
510
511
512
513
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe